Cognitive dysfunction in depression: Neurocircuitry and new therapeutic strategies

Neurobiology of Learning and Memory

Volumn 96, Issue 4, 2011, Pages 553-563

  Murrough, James W ^a   Iacoviello, Brian ^a,b   Neumeister, Alexander ^a,c   Charney, Dennis S ^a   Iosifescu, Dan V ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Cognition; Cognitive dysfunction; Depression; Emotion regulation; Neuroimaging; Neuropsychology; Therapeutics

Indexed keywords

ANTIDEPRESSANT AGENT; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; MEMANTINE; MODAFINIL; PLACEBO;

ATTENTION; ATTENTION DEFICIT DISORDER; CLINICAL RESEARCH; COGNITIVE BIAS; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; CORRELATION ANALYSIS; DISEASE DURATION; EMOTION; EXECUTIVE FUNCTION; HEALTH CARE COST; HUMAN; INFORMATION PROCESSING; MAJOR DEPRESSION; MEMORY DISORDER; MORBIDITY; MORTALITY; NEUROBIOLOGY; NEUROIMAGING; NONHUMAN; PREFRONTAL CORTEX; REVIEW; SHORT TERM MEMORY;

BRAIN; COGNITION DISORDERS; DEPRESSIVE DISORDER, MAJOR; HUMANS; NERVE NET; NEUROPSYCHOLOGICAL TESTS;

EID: 82355182063     PISSN: 10747427     EISSN: 10959564     Source Type: Journal    
DOI: 10.1016/j.nlm.2011.06.006     Document Type: Review

References (175)

1. Agid Y., Buzsaki G., Diamond D.M., Frackowiak R., Giedd J., Girault J.A., et al. How can drug discovery for psychiatric disorders be improved?. Nature Reviews Drug Discovery 2007, 6:189-201.
2. Airaksinen E., Larsson M., Lundberg I., Forsell Y. Cognitive functions in depressive disorders: Evidence from a population-based study. Psychological Medicine 2004, 34:83-91.
3. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience 1986, 9:357-381.
4. Alexopoulos G.S. The vascular depression hypothesis: 10 years later. Biological Psychiatry 2006, 60:1304-1305.
5. Alexopoulos G.S., Meyers B.S., Young R.C., Campbell S., Silbersweig D., Charlson M. 'Vascular depression' hypothesis. Archives of General Psychiatry 1997, 54:915-922.
6. Alloy L.B., Abramson L.Y., Whitehouse W.G., Hogan M.E., Panzarella C., Rose D.T. Prospective incidence of first onsets and recurrences of depression in individuals at high and low cognitive risk for depression. Journal of Abnormal Psychology 2006, 115:145-156.
7. Alloy L.B., Lipman A.J. Depression and selection of positive and negative social feedback: Motivated preference or cognitive balance?. Journal of Abnormal Psychology 1992, 101:310-313.
8. American Psychiatric Association. Task Force on DSM-IV (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR. (4th, text revision ed.). American Psychiatric Association: Washington, DC; New York.
9. Amir N., Beard C., Burns M., Bomyea J. Attention modification program in individuals with generalized anxiety disorder. Journal of Abnormal Psychology 2009, 118:28-33.
10. Austin M.P., Mitchell P., Goodwin G.M. Cognitive deficits in depression: Possible implications for functional neuropathology. The British Journal of Psychiatry: The Journal of Mental Science 2001, 178:200-206.
11. Bar-Haim Y. Research review: Attention bias modification (ABM): a novel treatment for anxiety disorders. Journal of Child Psychology and Psychiatry 2010, 51:859-870.
12. Baxter L.R., Schwartz J.M., Phelps M.E., Mazziotta J.C., Guze B.H., Selin C.E., et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Archives of General Psychiatry 1989, 46:243-250.
13. Beauregard M., Levesque J., Bourgouin P. Neural correlates of conscious self-regulation of emotion. The Journal of Neuroscience. The Official Journal of the Society for Neuroscience 2001, 21:RC165.
14. Beauregard M., Paquette V., Levesque J. Dysfunction in the neural circuitry of emotional self-regulation in major depressive disorder. NeuroReport 2006, 17:843-846.
15. Beck A.T. The evolution of the cognitive model of depression and its neurobiological correlates. The American Journal of Psychiatry 2008, 165:969-977.
16. Beck A.T., Rush A.J., Shaw B.F., Emery G. Cognitive therapy of depression 1979, New York, Guilford Press.
17. Bench C.J., Friston K.J., Brown R.G., Frackowiak R.S., Dolan R.J. Regional cerebral blood flow in depression measured by positron emission tomography: The relationship with clinical dimensions. Psychological Medicine 1993, 23:579-590.
18. Botvinick M.M., Braver T.S., Barch D.M., Carter C.S., Cohen J.D. Conflict monitoring and cognitive control. Psychological Review 2001, 108:624-652.
19. Bouhuys A.L., Geerts E., Gordijn M.C. Depressed patients' perceptions of facial emotions in depressed and remitted states are associated with relapse: A longitudinal study. The Journal of Nervous and Mental Disease 1999, 187:595-602.
20. Bradley B., Mathews A. Negative self-schemata in clinical depression. The British Journal of Clinical Psychology/The British Psychological Society 1983, 22(Pt 3):173-181.
21. Bradley B.P., Mogg K., Lee S.C. Attentional biases for negative information in induced and naturally occurring dysphoria. Behaviour Research and Therapy 1997, 35:911-927.
22. Bradley B.P., Mogg K., Millar N. Implicit memory bias in clinical and non-clinical depression. Behaviour Research and Therapy 1996, 34:865-879.
23. Bradley B.P., Mogg K., Williams R. Implicit and explicit memory for emotion-congruent information in clinical depression and anxiety. Behaviour Research and Therapy 1995, 33:755-770.
24. Brody A.L., Saxena S., Silverman D.H., Alborzian S., Fairbanks L.A., Phelps M.E., et al. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Research 1999, 91:127-139.
25. Browning M., Holmes E.A., Harmer C.J. The modification of attentional bias to emotional information: A review of the techniques, mechanisms, and relevance to emotional disorders. Cognitive, Affective & Behavioral Neuroscience 2010, 10:8-20.
26. Castaneda A.E., Tuulio-Henriksson A., Marttunen M., Suvisaari J., Lonnqvist J. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. Journal of Affective Disorders 2008, 106:1-27.
27. Cavada C., Company T., Tejedor J., Cruz-Rizzolo R.J., Reinoso-Suarez F. The anatomical connections of the macaque monkey orbitofrontal cortex. A review. Cerebral Cortex (New York, N.Y.: 1991) 2000, 10:220-242.
28. Chamberlain S.R., Muller U., Robbins T.W., Sahakian B.J. Neuropharmacological modulation of cognition. Current Opinion in Neurology 2006, 19:607-612.
29. Chamberlain S.R., Sahakian B.J. The neuropsychology of mood disorders. Current Psychiatry Reports 2006, 8:458-463.
30. Chen C.H., Ridler K., Suckling J., Williams S., Fu C.H., Merlo-Pich E., et al. Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biological Psychiatry 2007, 62:407-414.
31. Cohen R., Lohr I., Paul R., Boland R. Impairments of attention and effort among patients with major affective disorders. The Journal of Neuropsychiatry and Clinical Neurosciences 2001, 13:385-395.
32. Cuijpers P., Smit F., Bohlmeijer E., Hollon S.D., Andersson G. Efficacy of cognitive-behavioural therapy and other psychological treatments for adult depression: Meta-analytic study of publication bias. The British Journal of Psychiatry: The Journal of Mental Science 2010, 196:173-178.
33. Davidson R.J., Irwin W., Anderle M.J., Kalin N.H. The neural substrates of affective processing in depressed patients treated with venlafaxine. The American Journal of Psychiatry 2003, 160:64-75.
34. Davidson R.J., Lewis D.A., Alloy L.B., Amaral D.G., Bush G., Cohen J.D., et al. Neural and behavioral substrates of mood and mood regulation. Biological Psychiatry 2002, 52:478-502.
35. Davidson R.J., Pizzagalli D., Nitschke J.B., Putnam K. Depression: Perspectives from affective neuroscience. Annual Review of Psychology 2002, 53:545-574.
36. DeBattista C., Doghramji K., Menza M.A., Rosenthal M.H., Fieve R.R. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: A preliminary double-blind, placebo-controlled study. The Journal of Clinical Psychiatry 2003, 64:1057-1064. Modafinil in Depression Study Group.
37. DeBattista C., Lembke A., Solvason H.B., Ghebremichael R., Poirier J. A prospective trial of modafinil as an adjunctive treatment of major depression. Journal of Clinical Psychopharmacology 2004, 24:87-90.
38. Deckersbach T., Savage C.R., Reilly-Harrington N., Clark L., Sachs G., Rauch S.L. Episodic memory impairment in bipolar disorder and obsessive-compulsive disorder: The role of memory strategies. Bipolar Disorders 2004, 6:233-244.
39. DeRubeis R.J., Hollon S.D., Amsterdam J.D., Shelton R.C., Young P.R., Salomon R.M., et al. Cognitive therapy vs. medications in the treatment of moderate to severe depression. Archives of General Psychiatry 2005, 62:409-416.
40. Dickinson D., Ragland J.D., Gold J.M., Gur R.C. General and specific cognitive deficits in schizophrenia: Goliath defeats David?. Biological Psychiatry 2008, 64:823-827.
41. Donaldson C., Lam D., Mathews A. Rumination and attention in major depression. Behaviour Research and Therapy 2007, 45:2664-2678.
42. Drevets W.C. Orbitofrontal cortex function and structure in depression. Annals of the New York Academy of Sciences 2007, 1121:499-527.
43. Drevets W.C., Bogers W., Raichle M.E. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 2002, 12:527-544.
44. Drevets W.C., Price J.L., Furey M.L. Brain structural and functional abnormalities in mood disorders: Implications for neurocircuitry models of depression. Brain Structure & Function 2008, 213:93-118.
45. Drevets W.C., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., Raichle M.E. A functional anatomical study of unipolar depression. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 1992, 12:3628-3641.
46. Fava M., Graves L.M., Benazzi F., Scalia M.J., Iosifescu D.V., Alpert J.E., et al. A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. The Journal of Clinical Psychiatry 2006, 67:1754-1759.
47. Fava M., Thase M.E., DeBattista C. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. The Journal of Clinical Psychiatry 2005, 66:85-93.
48. Ferguson J.M., Shingleton R.N. An open-label, flexible-dose study of memantine in major depressive disorder. Clinical Neuropharmacology 2007, 30:136-144.
49. Ferrier I.N., Stanton B.R., Kelly T.P., Scott J. Neuropsychological function in euthymic patients with bipolar disorder. The British Journal of Psychiatry: The Journal of Mental Science 1999, 175:246-251.
50. Fitzgerald P.B., Laird A.R., Maller J., Daskalakis Z.J. A meta-analytic study of changes in brain activation in depression. Human Brain Mapping 2008, 29:683-695.
51. Fitzgerald P.B., Srithiran A., Benitez J., Daskalakis Z.Z., Oxley T.J., Kulkarni J., et al. An fMRI study of prefrontal brain activation during multiple tasks in patients with major depressive disorder. Human Brain Mapping 2008, 29:490-501.
52. Freedman L.J., Insel T.R., Smith Y. Subcortical projections of area 25 (subgenual cortex) of the macaque monkey. Journal of Comparative Neurology 2000, 421:172-188.
53. Fresco D.M., Heimberg R.G., Abramowitz A., Bertram T.L. The effect of a negative mood priming challenge on dysfunctional attitudes, explanatory style, and explanatory flexibility. The British Journal of Clinical Psychology/The British Psychological Society 2006, 45:167-183.
54. Fu C.H., Williams S.C., Brammer M.J., Suckling J., Kim J., Cleare A.J., et al. Neural responses to happy facial expressions in major depression following antidepressant treatment. The American Journal of Psychiatry 2007, 164:599-607.
55. Fu C.H., Williams S.C., Cleare A.J., Brammer M.J., Walsh N.D., Kim J., et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: A prospective, event-related functional magnetic resonance imaging study. Archives of General Psychiatry 2004, 61:877-889.
56. Gallagher H.L., Frith C.D. Functional imaging of 'theory of mind'. Trends in Cognitive Sciences 2003, 7:77-83.
57. Gohier B., Ferracci L., Surguladze S.A., Lawrence E., El Hage W., Kefi M.Z., et al. Cognitive inhibition and working memory in unipolar depression. Journal of Affective Disorders 2009, 116:100-105.
58. Goldapple K., Segal Z., Garson C., Lau M., Bieling P., Kennedy S., et al. Modulation of cortical-limbic pathways in major depression: Treatment-specific effects of cognitive behavior therapy. Archives of General Psychiatry 2004, 61:34-41.
59. Goldin P.R., McRae K., Ramel W., Gross J.J. The neural bases of emotion regulation: Reappraisal and suppression of negative emotion. Biological Psychiatry 2008, 63:577-586.
60. Gotlib I.H., Joormann J. Cognition and depression: Current status and future directions. Annual Review of Clinical Psychology 2010, 6:285-312.
61. Gotlib I.H., Kasch K.L., Traill S., Joormann J., Arnow B.A., Johnson S.L. Coherence and specificity of information-processing biases in depression and social phobia. Journal of Abnormal Psychology 2004, 113:386-398.
62. Gross J.J. Emotion regulation: Affective, cognitive, and social consequences. Psychophysiology 2002, 39:281-291.
63. Gross J.J., John O.P. Individual differences in two emotion regulation processes: Implications for affect, relationships, and well-being. Journal of Personality and Social Psychology 2003, 85:348-362.
64. Gur R.C., Erwin R.J., Gur R.E., Zwil A.S., Heimberg C., Kraemer H.C. Facial emotion discrimination: II. Behavioral findings in depression. Psychiatry Research 1992, 42:241-251.
65. Gusnard D.A., Akbudak E., Shulman G.L., Raichle M.E. Medial prefrontal cortex and self-referential mental activity: Relation to a default mode of brain function. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:4259-4264.
66. Hammar A., Ardal G. Cognitive functioning in major depression - A summary. Frontiers in Human Neuroscience 2009, 3:26.
67. Hammar A., Lund A., Hugdahl K. Long-lasting cognitive impairment in unipolar major depression: A 6-month follow-up study. Psychiatry Research 2003, 118:189-196.
68. Hammar A., Lund A., Hugdahl K. Selective impairment in effortful information processing in major depression. Journal of the International Neuropsychological Society: JINS 2003, 9:954-959.
69. Harmer C.J., O'Sullivan U., Favaron E., Massey-Chase R., Ayres R., Reinecke A., et al. Effect of acute antidepressant administration on negative affective bias in depressed patients. The American Journal of Psychiatry 2009, 166:1178-1184.
70. Hart C.L., Haney M., Vosburg S.K., Comer S.D., Gunderson E., Foltin R.W. Modafinil attenuates disruptions in cognitive performance during simulated night-shift work. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2006, 31:1526-1536.
71. Harvey P.O., Fossati P., Pochon J.B., Levy R., Lebastard G., Lehericy S., et al. Cognitive control and brain resources in major depression: An fMRI study using the n-back task. NeuroImage 2005, 26:860-869.
72. Harvey P.O., Le Bastard G., Pochon J.B., Levy R., Allilaire J.F., Dubois B., et al. Executive functions and updating of the contents of working memory in unipolar depression. Journal of Psychiatric Research 2004, 38:567-576.
73. Hasler G., Drevets W.C., Manji H.K., Charney D.S. Discovering endophenotypes for major depression. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2004, 29:1765-1781.
74. Henker B., Whalen C.K., Jamner L.D., Delfino R.J. Anxiety, affect, and activity in teenagers: Monitoring daily life with electronic diaries. Journal of the American Academy of Child and Adolescent Psychiatry 2002, 41:660-670.
75. Hugdahl K., Westerhausen R., Alho K., Medvedev S., Laine M., Hamalainen H. Attention and cognitive control: Unfolding the dichotic listening story. Scandinavian Journal of Psychology 2009, 50:11-22.
76. Insel T.R., Charney D.S. Research on major depression: Strategies and priorities. JAMA, the Journal of the American Medical Association 2003, 289:3167-3168.
77. Iosifescu D.V. Treating depression in the medically ill. The Psychiatric Clinics of North America 2007, 30:77-90.
78. Iosifescu D.V., Moore C.M., Deckersbach T., Tilley C.A., Ostacher M.J., Sachs G.S., et al. Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: A proof-of-concept study. CNS Neuroscience & Therapeutics 2009, 15:309-319.
79. Iosifescu D.V., Papakostas G.I., Lyoo I.K., Lee H.K., Renshaw P.F., Alpert J.E., et al. Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part I). Psychiatry Research 2005, 140:291-299.
80. Jacobsen F.M., Comas-Diaz L. Donepezil for psychotropic-induced memory loss. The Journal of Clinical Psychiatry 1999, 60:698-704.
81. Jaeger J., Berns S., Uzelac S., Davis-Conway S. Neurocognitive deficits and disability in major depressive disorder. Psychiatry Research 2006, 145:39-48.
82. Johnstone T., van Reekum C.M., Urry H.L., Kalin N.H., Davidson R.J. Failure to regulate: Counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2007, 27:8877-8884.
83. Joormann J., Gotlib I.H. Selective attention to emotional faces following recovery from depression. Journal of Abnormal Psychology 2007, 116:80-85.
84. Keedwell P.A., Drapier D., Surguladze S., Giampietro V., Brammer M., Phillips M. Subgenual cingulate and visual cortex responses to sad faces predict clinical outcome during antidepressant treatment for depression. Journal of Affective Disorders 2010, 120:120-125.
85. Keilp J.G., Gorlyn M., Oquendo M.A., Burke A.K., Mann J.J. Attention deficit in depressed suicide attempters. Psychiatry Research 2008, 159:7-17.
86. Kennedy S.H., Evans K.R., Kruger S., Mayberg H.S., Meyer J.H., McCann S., et al. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. The American Journal of Psychiatry 2001, 158:899-905.
87. Kennedy S.H., Konarski J.Z., Segal Z.V., Lau M.A., Bieling P.J., McIntyre R.S., et al. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. The American Journal of Psychiatry 2007, 164:778-788.
88. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA, the Journal of the American Medical Association 2003, 289:3095-3105.
89. Kim S.H., Hamann S. Neural correlates of positive and negative emotion regulation. Journal of Cognitive Neuroscience 2007, 19:776-798.
90. Koetsier G.C., Volkers A.C., Tulen J.H., Passchier J., van den Broek W.W., Bruijn J.A. CPT performance in major depressive disorder before and after treatment with imipramine or fluvoxamine. Journal of Psychiatric Research 2002, 36:391-397.
91. Kringelbach M.L., Rolls E.T. The functional neuroanatomy of the human orbitofrontal cortex: Evidence from neuroimaging and neuropsychology. Progress in Neurobiology 2004, 72:341-372.
92. Krishnan K.R., Hays J.C., Blazer D.G. MRI-defined vascular depression. The American Journal of Psychiatry 1997, 154:497-501.
93. Lampe I.K., Sitskoorn M.M., Heeren T.J. Effects of recurrent major depressive disorder on behavior and cognitive function in female depressed patients. Psychiatry Research 2004, 125:73-79.
94. Landro N.I., Stiles T.C., Sletvold H. Neuropsychological function in nonpsychotic unipolar major depression. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 2001, 14:233-240.
95. Lane R.D., Fink G.R., Chau P.M., Dolan R.J. Neural activation during selective attention to subjective emotional responses. NeuroReport 1997, 8:3969-3972.
96. LeDoux J.E. Emotion circuits in the brain. Annual Review of Neuroscience 2000, 23:155-184.
97. LeMoult J., Joormann J., Sherdell L., Wright Y., Gotlib I.H. Identification of emotional facial expressions following recovery from depression. Journal of Abnormal Psychology 2009, 118:828-833.
98. Levens S.M., Gotlib I.H. Impaired selection of relevant positive information in depression. Depression and Anxiety 2009, 26:403-410.
99. Levesque J., Eugene F., Joanette Y., Paquette V., Mensour B., Beaudoin G., et al. Neural circuitry underlying voluntary suppression of sadness. Biological Psychiatry 2003, 53:502-510.
100. Liu S.K., Chiu C.H., Chang C.J., Hwang T.J., Hwu H.G., Chen W.J. Deficits in sustained attention in schizophrenia and affective disorders: Stable versus state-dependent markers. The American Journal of Psychiatry 2002, 159:975-982.
101. MacLeod C., Rutherford E., Campbell L., Ebsworthy G., Holker L. Selective attention and emotional vulnerability: Assessing the causal basis of their association through the experimental manipulation of attentional bias. Journal of Abnormal Psychology 2002, 111:107-123.
102. Madras B.K., Xie Z., Lin Z., Jassen A., Panas H., Lynch L., et al. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. The Journal of Pharmacology and Experimental Therapeutics 2006, 319:561-569.
103. Majer M., Ising M., Kunzel H., Binder E.B., Holsboer F., Modell S., et al. Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disorders. Psychological Medicine 2004, 34:1453-1463.
104. Manji H.K., Drevets W.C., Charney D.S. The cellular neurobiology of depression. Nature Medicine 2001, 7:541-547.
105. Mann J.J. Neurobiology of suicidal behaviour. Nature Reviews Neuroscience 2003, 4:819-828.
106. Markela-Lerenc J., Kaiser S., Fiedler P., Weisbrod M., Mundt C. Stroop performance in depressive patients: A preliminary report. Journal of Affective Disorders 2006, 94:261-267.
107. Martinot J.L., Hardy P., Feline A., Huret J.D., Mazoyer B., Attar-Levy D., et al. Left prefrontal glucose hypometabolism in the depressed state: A confirmation. The American Journal of Psychiatry 1990, 147:1313-1317.
108. Mathew S.J. Treatment-resistant depression: Recent developments and future directions. Depression and Anxiety 2008, 25:989-992.
109. Mathew S.J., Manji H.K., Charney D.S. Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2008, 33:2080-2092.
110. Mathew S.J., Murrough J.W., aan het Rot M., Collins K.A., Reich D.L., Charney D.S. Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: A pilot randomized, placebo-controlled continuation trial. The International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2010, 13:71-82.
111. Mathews A., MacLeod C. Cognitive vulnerability to emotional disorders. Annual Review of Clinical Psychology 2005, 1:167-195.
112. Mayberg H.S. Modulating dysfunctional limbic-cortical circuits in depression: Towards development of brain-based algorithms for diagnosis and optimised treatment. British Medical Bulletin 2003, 65:193-207.
113. Mayberg H.S., Brannan S.K., Mahurin R.K., Jerabek P.A., Brickman J.S., Tekell J.L., et al. Cingulate function in depression: A potential predictor of treatment response. NeuroReport 1997, 8:1057-1061.
114. Mayberg H.S., Brannan S.K., Tekell J.L., Silva J.A., Mahurin R.K., McGinnis S., et al. Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response. Biological Psychiatry 2000, 48:830-843.
115. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., et al. Reciprocal limbic-cortical function and negative mood: Converging PET findings in depression and normal sadness. The American Journal of Psychiatry 1999, 156:675-682.
116. Minzenberg M.J., Carter C.S. Modafinil: A review of neurochemical actions and effects on cognition. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2008, 33:1477-1502.
117. Muller U., Steffenhagen N., Regenthal R., Bublak P. Effects of modafinil on working memory processes in humans. Psychopharmacology 2004, 177:161-169.
118. Murphy F.C., Sahakian B.J., Rubinsztein J.S., Michael A., Rogers R.D., Robbins T.W., et al. Emotional bias and inhibitory control processes in mania and depression. Psychological Medicine 1999, 29:1307-1321.
119. Murray L.A., Whitehouse W.G., Alloy L.B. Mood congruence and depressive deficits in memory: A forced-recall analysis. Memory (Hove, England) 1999, 7:175-196.
120. Murrough J.W., Charney D.S. Cracking the moody brain: Lifting the mood with ketamine. Nature Medicine 2010, 16:1384-1385.
121. Naismith S.L., Hickie I.B., Turner K., Little C.L., Winter V., Ward P.B., et al. Neuropsychological performance in patients with depression is associated with clinical, etiological and genetic risk factors. Journal of Clinical and Experimental Neuropsychology 2003, 25:866-877.
122. Nelson J.C., Charney D.S. The symptoms of major depressive illness. The American Journal of Psychiatry 1981, 138:1-13.
123. Neumeister A., Nugent A.C., Waldeck T., Geraci M., Schwarz M., Bonne O., et al. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Archives of General Psychiatry 2004, 61:765-773.
124. Ochsner K.N., Bunge S.A., Gross J.J., Gabrieli J.D. Rethinking feelings: An FMRI study of the cognitive regulation of emotion. Journal of Cognitive Neuroscience 2002, 14:1215-1229.
125. Ochsner K.N., Gross J.J. The cognitive control of emotion. Trends in Cognitive Sciences 2005, 9:242-249.
126. Ochsner K.N., Knierim K., Ludlow D.H., Hanelin J., Ramachandran T., Glover G., et al. Reflecting upon feelings: An fMRI study of neural systems supporting the attribution of emotion to self and other. Journal of Cognitive Neuroscience 2004, 16:1746-1772.
127. Ochsner K.N., Ray R.D., Cooper J.C., Robertson E.R., Chopra S., Gabrieli J.D., et al. For better or for worse: Neural systems supporting the cognitive down- and up-regulation of negative emotion. NeuroImage 2004, 23:483-499.
128. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:13290-13295.
129. Ongur D., Price J.L. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cerebral Cortex (New York, N.Y.: 1991) 2000, 10:206-219.
130. Paelecke-Habermann Y., Pohl J., Leplow B. Attention and executive functions in remitted major depression patients. Journal of Affective Disorders 2005, 89:125-135.
131. Paul I.A., Skolnick P. Glutamate and depression: Clinical and preclinical studies. Annals of the New York Academy of Sciences 2003, 1003:250-272.
132. Phan K.L., Fitzgerald D.A., Nathan P.J., Moore G.J., Uhde T.W., Tancer M.E. Neural substrates for voluntary suppression of negative affect: A functional magnetic resonance imaging study. Biological Psychiatry 2005, 57:210-219.
133. Phillips M.L., Drevets W.C., Rauch S.L., Lane R. Neurobiology of emotion perception I: The neural basis of normal emotion perception. Biological Psychiatry 2003, 54:504-514.
134. Phillips M.L., Drevets W.C., Rauch S.L., Lane R. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biological Psychiatry 2003, 54:515-528.
135. Pizzagalli D.A., Oakes T.R., Fox A.S., Chung M.K., Larson C.L., Abercrombie H.C., et al. Functional but not structural subgenual prefrontal cortex abnormalities in melancholia. Molecular Psychiatry 2004, 9(325):393-405.
136. Porter R.J., Gallagher P., Thompson J.M., Young A.H. Neurocognitive impairment in drug-free patients with major depressive disorder. The British Journal of Psychiatry: The Journal of Mental Science 2003, 182:214-220.
137. Price J.L. Prefrontal cortical networks related to visceral function and mood. Annals of the New York Academy of Sciences 1999, 877:383-396.
138. Price J.L., Drevets W.C. Neurocircuitry of mood disorders. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2010, 35:192-216.
139. Randall D.C., Viswanath A., Bharania P., Elsabagh S.M., Hartley D.E., Shneerson J.M., et al. Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived?. Journal of Clinical Psychopharmacology 2005, 25:175-179.
140. Rasetti R., Mattay V.S., Stankevich B., Skjei K., Blasi G., Sambataro F., et al. Modulatory effects of modafinil on neural circuits regulating emotion and cognition. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2010, 35:2101-2109.
141. Reischies F.M., Neu P. Comorbidity of mild cognitive disorder and depression - A neuropsychological analysis. European Archives of Psychiatry and Clinical Neuroscience 2000, 250:186-193.
142. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. The American Journal of Psychiatry 2006, 163:1905-1917.
143. Saxena S., Brody A.L., Ho M.L., Alborzian S., Ho M.K., Maidment K.M., et al. Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently. Biological Psychiatry 2001, 50:159-170.
144. Saxena S., Brody A.L., Ho M.L., Zohrabi N., Maidment K.M., Baxter L.R. Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. The American Journal of Psychiatry 2003, 160:522-532.
145. Schaefer S.M., Jackson D.C., Davidson R.J., Aguirre G.K., Kimberg D.Y., Thompson-Schill S.L. Modulation of amygdalar activity by the conscious regulation of negative emotion. Journal of Cognitive Neuroscience 2002, 14:913-921.
146. Schmidt N.B., Richey J.A., Buckner J.D., Timpano K.R. Attention training for generalized social anxiety disorder. Journal of Abnormal Psychology 2009, 118:5-14.
147. Schoning S., Zwitserlood P., Engelien A., Behnken A., Kugel H., Schiffbauer H., et al. Working-memory fMRI reveals cingulate hyperactivation in euthymic major depression. Human Brain Mapping 2009, 30:2746-2756.
148. Schrauwen E., Ghaemi S.N. Galantamine treatment of cognitive impairment in bipolar disorder: Four cases. Bipolar Disorders 2006, 8:196-199.
149. Schubert M.H., Young K.A., Hicks P.B. Galantamine improves cognition in schizophrenic patients stabilized on risperidone. Biological Psychiatry 2006, 60:530-533.
150. Seminowicz D.A., Mayberg H.S., McIntosh A.R., Goldapple K., Kennedy S., Segal Z., et al. Limbic-frontal circuitry in major depression: A path modeling metanalysis. NeuroImage 2004, 22:409-418.
151. Sheline Y.I., Barch D.M., Donnelly J.M., Ollinger J.M., Snyder A.Z., Mintun M.A. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: An fMRI study. Biological Psychiatry 2001, 50:651-658.
152. Sheline Y.I., Pieper C.F., Barch D.M., Welsh-Bohmer K., McKinstry R.C., MacFall J.R., et al. Support for the vascular depression hypothesis in late-life depression: Results of a 2-site, prospective, antidepressant treatment trial. Archives of General Psychiatry 2010, 67:277-285.
153. Siegle G.J., Thompson W., Carter C.S., Steinhauer S.R., Thase M.E. Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: Related and independent features. Biological Psychiatry 2007, 61:198-209.
154. Simons C.J., Jacobs N., Derom C., Thiery E., Jolles J., van Os J., et al. Cognition as predictor of current and follow-up depressive symptoms in the general population. Acta Psychiatrica Scandinavica 2009, 120:45-52.
155. Sloan D.M., Bradley M.M., Dimoulas E., Lang P.J. Looking at facial expressions: Dysphoria and facial EMG. Biological Psychology 2002, 60:79-90.
156. Surguladze S., Brammer M.J., Keedwell P., Giampietro V., Young A.W., Travis M.J., et al. A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder. Biological Psychiatry 2005, 57:201-209.
157. Surguladze S.A., Young A.W., Senior C., Brebion G., Travis M.J., Phillips M.L. Recognition accuracy and response bias to happy and sad facial expressions in patients with major depression. Neuropsychology 2004, 18:212-218.
158. Taylor S.F., Liberzon I. Neural correlates of emotion regulation in psychopathology. Trends in Cognitive Sciences 2007, 11:413-418.
159. Taylor Tavares J.V., Clark L., Cannon D.M., Erickson K., Drevets W.C., Sahakian B.J. Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II depression. Biological Psychiatry 2007, 62:917-924.
160. Teng C.T., Demetrio F.N. Memantine may acutely improve cognition and have a mood stabilizing effect in treatment-resistant bipolar disorder. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 2006, 28:252-254.
161. Thomas A.J., O'Brien J.T., Davis S., Ballard C., Barber R., Kalaria R.N., et al. Ischemic basis for deep white matter hyperintensities in major depression: A neuropathological study. Archives of General Psychiatry 2002, 59:785-792.
162. Trivedi M.H., Rush A.J., Wisniewski S.R., Nierenberg A.A., Warden D., Ritz L., et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. The American Journal of Psychiatry 2006, 163:28-40.
163. Urry H.L., van Reekum C.M., Johnstone T., Kalin N.H., Thurow M.E., Schaefer H.S., et al. Amygdala and ventromedial prefrontal cortex are inversely coupled during regulation of negative affect and predict the diurnal pattern of cortisol secretion among older adults. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2006, 26:4415-4425.
164. Vythilingam M., Vermetten E., Anderson G.M., Luckenbaugh D., Anderson E.R., Snow J., et al. Hippocampal volume, memory, and cortisol status in major depressive disorder: Effects of treatment. Biological Psychiatry 2004, 56:101-112.
165. Wager T.D., Davidson M.L., Hughes B.L., Lindquist M.A., Ochsner K.N. Prefrontal-subcortical pathways mediating successful emotion regulation. Neuron 2008, 59:1037-1050.
166. Wager T.D., Smith E.E. Neuroimaging studies of working memory: A meta-analysis. Cognitive, Affective & Behavioral Neuroscience 2003, 3:255-274.
167. Wagner A.D., Pare-Blagoev E.J., Clark J., Poldrack R.A. Recovering meaning: Left prefrontal cortex guides controlled semantic retrieval. Neuron 2001, 31:329-338.
168. Wang P.S., Beck A.L., Berglund P., McKenas D.K., Pronk N.P., Simon G.E., et al. Effects of major depression on moment-in-time work performance. The American Journal of Psychiatry 2004, 161:1885-1891.
169. Watkins P.C., Vache K., Verney S.P., Muller S., Mathews A. Unconscious mood-congruent memory bias in depression. Journal of Abnormal Psychology 1996, 105:34-41.
170. Weiland-Fiedler P., Erickson K., Waldeck T., Luckenbaugh D.A., Pike D., Bonne O., et al. Evidence for continuing neuropsychological impairments in depression. Journal of Affective Disorders 2004, 82:253-258.
171. Wells T.T., Beevers C.G. Biased attention and dysphoria: Manipulating selective attention reduces subsequent depressive symptoms. Cognition and Emotion 2010, 24:719-728.
172. World Health Organization World health report 2001 2001, New Understanding, New Hope, Mental Health.
173. Yoon K.L., Joormann J., Gotlib I.H. Judging the intensity of facial expressions of emotion: Depression-related biases in the processing of positive affect. Journal of Abnormal Psychology 2009, 118:223-228.
174. Zarate C., Machado-Vieira R., Henter I., Ibrahim L., Diazgranados N., Salvadore G. Glutamatergic modulators: The future of treating mood disorders?. Harvard Review of Psychiatry 2010, 18:293-303.
175. Zarate C.A., Singh J.B., Carlson P.J., Brutsche N.E., Ameli R., Luckenbaugh D.A., et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry 2006, 63:856-864.